Phallic Growth After hCG: A Clinical Index of Androgen Responsiveness

Clinical and hormonal responses to a standard three-day human chorionic gonadotropin (hCG)-stimulation test (1,500 IU given intramuscularly for three days) were studied in six neonates with ambiguous genitalia. All patients were eventually determined to be 46,XY genetic males with a microphallus and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pediatrics 1993-06, Vol.32 (6), p.329-333
Hauptverfasser: Almaguer, Manuela C., Saenger, Paul, Linder, Barbara L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 333
container_issue 6
container_start_page 329
container_title Clinical pediatrics
container_volume 32
creator Almaguer, Manuela C.
Saenger, Paul
Linder, Barbara L.
description Clinical and hormonal responses to a standard three-day human chorionic gonadotropin (hCG)-stimulation test (1,500 IU given intramuscularly for three days) were studied in six neonates with ambiguous genitalia. All patients were eventually determined to be 46,XY genetic males with a microphallus and various other genital abnormalities. None had an enzymatic defect in steroidogenesis or a 5α-reductase deficiency, as determined by standard adrenocorticotropic hormone (ACTH) and hCG testing. All patients demonstrated penile growth (0.25 to 0.75 cm) within five days of hCG administration, with four of six patients achieving a normal penile length (>2.0 cm) by 48 hours after the last of three daily hCG injections. Androgen responsiveness suggested by phallic growth may help support a male sex assignment in such infants.
doi_str_mv 10.1177/000992289303200602
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75890289</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_000992289303200602</sage_id><sourcerecordid>75890289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-fc0f60fbba89748f841312907242dfd4c30331a5ee61d0f42f64cbf1b1582ca03</originalsourceid><addsrcrecordid>eNp9kMFLwzAUxoMoc07vIgg7iLe695K0SY5j6BQGetBzSNPEdXTrTFrE_96WlV0ET-_w_b7vvfcRcoPwgCjEDACUolQqBowCZEBPyBgVkwkVIE7JuAeSnjgnFzFuAJBBykZkJJliIuVjcv22NlVV2uky1N_Nejr3jQvT9WJ5Sc68qaK7GuaEfDw9vi-ek9Xr8mUxXyWWoWwSb8Fn4PPcSCW49JIjQ6pAUE4LX3DbncbQpM5lWIDn1Gfc5h5zTCW1BtiE3B9y96H-al1s9LaM1lWV2bm6jVqkUkH_4oTQA2hDHWNwXu9DuTXhRyPovg79t47OdDukt_nWFUfL8H-n3w26idZUPpidLeMR41JgxnpsdsCi-XR6U7dh13Xy3-JfVvdxBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75890289</pqid></control><display><type>article</type><title>Phallic Growth After hCG: A Clinical Index of Androgen Responsiveness</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Almaguer, Manuela C. ; Saenger, Paul ; Linder, Barbara L.</creator><creatorcontrib>Almaguer, Manuela C. ; Saenger, Paul ; Linder, Barbara L.</creatorcontrib><description>Clinical and hormonal responses to a standard three-day human chorionic gonadotropin (hCG)-stimulation test (1,500 IU given intramuscularly for three days) were studied in six neonates with ambiguous genitalia. All patients were eventually determined to be 46,XY genetic males with a microphallus and various other genital abnormalities. None had an enzymatic defect in steroidogenesis or a 5α-reductase deficiency, as determined by standard adrenocorticotropic hormone (ACTH) and hCG testing. All patients demonstrated penile growth (0.25 to 0.75 cm) within five days of hCG administration, with four of six patients achieving a normal penile length (&gt;2.0 cm) by 48 hours after the last of three daily hCG injections. Androgen responsiveness suggested by phallic growth may help support a male sex assignment in such infants.</description><identifier>ISSN: 0009-9228</identifier><identifier>EISSN: 1938-2707</identifier><identifier>DOI: 10.1177/000992289303200602</identifier><identifier>PMID: 8393754</identifier><identifier>CODEN: CPEDAM</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adrenocorticotropic Hormone ; Androgens - blood ; Biological and medical sciences ; Genital system. Reproduction ; Gonadal Dysgenesis, 46,XY - blood ; Gonadal Dysgenesis, 46,XY - diagnosis ; Gonadal Dysgenesis, 46,XY - drug therapy ; Gonadal Dysgenesis, 46,XY - genetics ; Growth Hormone - administration &amp; dosage ; Growth Hormone - therapeutic use ; Humans ; Infant, Newborn ; Injections, Intramuscular ; Karyotyping ; Male ; Medical sciences ; Penis - abnormalities ; Penis - drug effects ; Penis - growth &amp; development ; Pharmacology. Drug treatments</subject><ispartof>Clinical pediatrics, 1993-06, Vol.32 (6), p.329-333</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c318t-fc0f60fbba89748f841312907242dfd4c30331a5ee61d0f42f64cbf1b1582ca03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/000992289303200602$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/000992289303200602$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21799,27903,27904,43600,43601</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4871634$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8393754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Almaguer, Manuela C.</creatorcontrib><creatorcontrib>Saenger, Paul</creatorcontrib><creatorcontrib>Linder, Barbara L.</creatorcontrib><title>Phallic Growth After hCG: A Clinical Index of Androgen Responsiveness</title><title>Clinical pediatrics</title><addtitle>Clin Pediatr (Phila)</addtitle><description>Clinical and hormonal responses to a standard three-day human chorionic gonadotropin (hCG)-stimulation test (1,500 IU given intramuscularly for three days) were studied in six neonates with ambiguous genitalia. All patients were eventually determined to be 46,XY genetic males with a microphallus and various other genital abnormalities. None had an enzymatic defect in steroidogenesis or a 5α-reductase deficiency, as determined by standard adrenocorticotropic hormone (ACTH) and hCG testing. All patients demonstrated penile growth (0.25 to 0.75 cm) within five days of hCG administration, with four of six patients achieving a normal penile length (&gt;2.0 cm) by 48 hours after the last of three daily hCG injections. Androgen responsiveness suggested by phallic growth may help support a male sex assignment in such infants.</description><subject>Adrenocorticotropic Hormone</subject><subject>Androgens - blood</subject><subject>Biological and medical sciences</subject><subject>Genital system. Reproduction</subject><subject>Gonadal Dysgenesis, 46,XY - blood</subject><subject>Gonadal Dysgenesis, 46,XY - diagnosis</subject><subject>Gonadal Dysgenesis, 46,XY - drug therapy</subject><subject>Gonadal Dysgenesis, 46,XY - genetics</subject><subject>Growth Hormone - administration &amp; dosage</subject><subject>Growth Hormone - therapeutic use</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Injections, Intramuscular</subject><subject>Karyotyping</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Penis - abnormalities</subject><subject>Penis - drug effects</subject><subject>Penis - growth &amp; development</subject><subject>Pharmacology. Drug treatments</subject><issn>0009-9228</issn><issn>1938-2707</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFLwzAUxoMoc07vIgg7iLe695K0SY5j6BQGetBzSNPEdXTrTFrE_96WlV0ET-_w_b7vvfcRcoPwgCjEDACUolQqBowCZEBPyBgVkwkVIE7JuAeSnjgnFzFuAJBBykZkJJliIuVjcv22NlVV2uky1N_Nejr3jQvT9WJ5Sc68qaK7GuaEfDw9vi-ek9Xr8mUxXyWWoWwSb8Fn4PPcSCW49JIjQ6pAUE4LX3DbncbQpM5lWIDn1Gfc5h5zTCW1BtiE3B9y96H-al1s9LaM1lWV2bm6jVqkUkH_4oTQA2hDHWNwXu9DuTXhRyPovg79t47OdDukt_nWFUfL8H-n3w26idZUPpidLeMR41JgxnpsdsCi-XR6U7dh13Xy3-JfVvdxBw</recordid><startdate>19930601</startdate><enddate>19930601</enddate><creator>Almaguer, Manuela C.</creator><creator>Saenger, Paul</creator><creator>Linder, Barbara L.</creator><general>SAGE Publications</general><general>Westminster</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930601</creationdate><title>Phallic Growth After hCG</title><author>Almaguer, Manuela C. ; Saenger, Paul ; Linder, Barbara L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-fc0f60fbba89748f841312907242dfd4c30331a5ee61d0f42f64cbf1b1582ca03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adrenocorticotropic Hormone</topic><topic>Androgens - blood</topic><topic>Biological and medical sciences</topic><topic>Genital system. Reproduction</topic><topic>Gonadal Dysgenesis, 46,XY - blood</topic><topic>Gonadal Dysgenesis, 46,XY - diagnosis</topic><topic>Gonadal Dysgenesis, 46,XY - drug therapy</topic><topic>Gonadal Dysgenesis, 46,XY - genetics</topic><topic>Growth Hormone - administration &amp; dosage</topic><topic>Growth Hormone - therapeutic use</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Injections, Intramuscular</topic><topic>Karyotyping</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Penis - abnormalities</topic><topic>Penis - drug effects</topic><topic>Penis - growth &amp; development</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Almaguer, Manuela C.</creatorcontrib><creatorcontrib>Saenger, Paul</creatorcontrib><creatorcontrib>Linder, Barbara L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Almaguer, Manuela C.</au><au>Saenger, Paul</au><au>Linder, Barbara L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phallic Growth After hCG: A Clinical Index of Androgen Responsiveness</atitle><jtitle>Clinical pediatrics</jtitle><addtitle>Clin Pediatr (Phila)</addtitle><date>1993-06-01</date><risdate>1993</risdate><volume>32</volume><issue>6</issue><spage>329</spage><epage>333</epage><pages>329-333</pages><issn>0009-9228</issn><eissn>1938-2707</eissn><coden>CPEDAM</coden><abstract>Clinical and hormonal responses to a standard three-day human chorionic gonadotropin (hCG)-stimulation test (1,500 IU given intramuscularly for three days) were studied in six neonates with ambiguous genitalia. All patients were eventually determined to be 46,XY genetic males with a microphallus and various other genital abnormalities. None had an enzymatic defect in steroidogenesis or a 5α-reductase deficiency, as determined by standard adrenocorticotropic hormone (ACTH) and hCG testing. All patients demonstrated penile growth (0.25 to 0.75 cm) within five days of hCG administration, with four of six patients achieving a normal penile length (&gt;2.0 cm) by 48 hours after the last of three daily hCG injections. Androgen responsiveness suggested by phallic growth may help support a male sex assignment in such infants.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>8393754</pmid><doi>10.1177/000992289303200602</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9228
ispartof Clinical pediatrics, 1993-06, Vol.32 (6), p.329-333
issn 0009-9228
1938-2707
language eng
recordid cdi_proquest_miscellaneous_75890289
source MEDLINE; SAGE Complete
subjects Adrenocorticotropic Hormone
Androgens - blood
Biological and medical sciences
Genital system. Reproduction
Gonadal Dysgenesis, 46,XY - blood
Gonadal Dysgenesis, 46,XY - diagnosis
Gonadal Dysgenesis, 46,XY - drug therapy
Gonadal Dysgenesis, 46,XY - genetics
Growth Hormone - administration & dosage
Growth Hormone - therapeutic use
Humans
Infant, Newborn
Injections, Intramuscular
Karyotyping
Male
Medical sciences
Penis - abnormalities
Penis - drug effects
Penis - growth & development
Pharmacology. Drug treatments
title Phallic Growth After hCG: A Clinical Index of Androgen Responsiveness
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T13%3A10%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phallic%20Growth%20After%20hCG:%20A%20Clinical%20Index%20of%20Androgen%20Responsiveness&rft.jtitle=Clinical%20pediatrics&rft.au=Almaguer,%20Manuela%20C.&rft.date=1993-06-01&rft.volume=32&rft.issue=6&rft.spage=329&rft.epage=333&rft.pages=329-333&rft.issn=0009-9228&rft.eissn=1938-2707&rft.coden=CPEDAM&rft_id=info:doi/10.1177/000992289303200602&rft_dat=%3Cproquest_cross%3E75890289%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75890289&rft_id=info:pmid/8393754&rft_sage_id=10.1177_000992289303200602&rfr_iscdi=true